MeSH Browser

MeSH Heading: HIV Seropositivity
Tree Number(s): C01.221.250.875.500; C01.221.812.640.400.500; C01.778.640.400.500; C01.925.782.815.616.400.500; C01.925.813.400.500; C12.100.937.640.400.500; C20.673.480.500
Unique ID: D006679
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D006679
Annotation: note category; HIV SERONEGATIVITY (Cat G) is also available; /‌diag /‌immunol permitted but use caution; coord IM with HIV-1 /‌immunol (IM) or HIV-2 /‌immunol (IM); do not confuse with HIV SEROPREVALENCE, an epidemiol concept; DF: HIV SEROPOS
Scope Note: Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
Entry Version: HIV SEROPOS
Entry Term(s): AIDS Seroconversion; AIDS Seropositivity; Anti-HIV Positivity; HIV Antibody Positivity; HIV Seroconversion; HTLV-III Seroconversion; HTLV-III Seropositivity
Previous Indexing: Acquired Immunodeficiency Syndrome (1984-1987); Antibodies, Viral (1983-1987); HTLV-III (1987); Human T-Cell Leukemia Virus (1984-1986)
See Also: HIV Seronegativity; HIV Seroprevalence
Public MeSH Note: 88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93
History Note: 88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93
Date Established: 1988/01/01
Date of Entry: 1987/09/28
Revision Date: 2021/06/30

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

drug therapy (DT)

economics (EC)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

psychology (PX)

rehabilitation (RH)

therapy (TH)

transmission (TM)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0010471
Scope Note: Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
Terms: HIV Seropositivity Preferred Term
Term UI T020171
Date01/01/1999
LexicalTag ACX
ThesaurusID BIOETHICS (1989); AIDS Seropositivity
Term UI T020167
Date09/28/1987
LexicalTag NON
ThesaurusID UNK (19XX); Anti-HIV Positivity
Term UI T020168
Date09/28/1987
LexicalTag NON
ThesaurusID UNK (19XX); HTLV-III Seropositivity
Term UI T020173
Date09/28/1987
LexicalTag NON
ThesaurusID UNK (19XX); HIV Seroconversion
Term UI T020170
Date12/09/1988
LexicalTag NON
ThesaurusID NLM (1990); HTLV-III Seroconversion
Term UI T020172
Date12/09/1988
LexicalTag NON
ThesaurusID NLM (1990); AIDS Seroconversion
Term UI T020166
Date12/09/1988
LexicalTag NON
ThesaurusID NLM (1990); HIV Antibody Positivity
Term UI T020169
Date09/28/1987
LexicalTag NON
ThesaurusID UNK (19XX)

HIV Seropositivity MeSH Descriptor Data 2024